These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis. Alexia C; Bras M; Fallot G; Vadrot N; Daniel F; Lasfer M; Tamouza H; Groyer A Ann N Y Acad Sci; 2006 Dec; 1090():1-17. PubMed ID: 17384242 [TBL] [Abstract][Full Text] [Related]
12. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
13. Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver. Nakagawa Y; Aoki N; Aoyama K; Shimizu H; Shimano H; Yamada N; Miyazaki H Zoolog Sci; 2005 Feb; 22(2):169-75. PubMed ID: 15738637 [TBL] [Abstract][Full Text] [Related]
14. Loss of protein tyrosine phosphatase 1B increases IGF-I receptor tyrosine phosphorylation but does not rescue retinal defects in IRS2-deficient mice. Arroba AI; Revuelta-Cervantes J; Menes L; González-Rodríguez Á; Pardo V; de la Villa P; Burks DJ; Valverde ÁM Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4215-25. PubMed ID: 23702782 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250 [TBL] [Abstract][Full Text] [Related]
17. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells. Azar ZM; Mehdi MZ; Srivastava AK Can J Physiol Pharmacol; 2006 Jul; 84(7):777-86. PubMed ID: 16998541 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799 [TBL] [Abstract][Full Text] [Related]
19. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin. Guvakova MA; Surmacz E Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590 [TBL] [Abstract][Full Text] [Related]
20. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer. Blanquart C; Boute N; Lacasa D; Issad T Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]